Tandem Diabetes Care shared that its Capillary Biomedical (CapBio) subsidiary won FDA 510(k) clearance for a new infusion set.

Novo Nordisk A/S’s decision to stop making insulin pens will narrow treatment options for children with diabetes unless ...

The global Injectable Drug Delivery Market, valued at US$633.7 billion in 2024, is forecasted to grow at a robust CAGR of 8.4 ...

Continuous glucose monitoring provides a new, less invasive method for evaluating diabetes risk. Fluctuations in blood ...

Key players in the Intradermal Injection market are Becton Dickinson, Cardinal Health, West Pharmaceuticals services, Terumo Corporation, Nanopass, Pharmajet, Idevax, Enusung, Crossject, and Hindustan ...

Medtronic is seeking Food and Drug Administration clearance for an interoperable version of its latest insulin pump, an important step in the manufacturer’s collaboration with diabetes technology ...

Residents said he used a needle to inject a substance in a cat. Another resident found their cat hanging from a tree. Police have received multiple reports from residents, some dating back to two ...

Vials need separate insulin syringes. “Other forms of insulin, including human insulins from Novo Nordisk, will continue to be available in vials and devices for patients across India. In order to ...

This might lead to limited access as insulin delivery from pen devices is preferred by a huge majority of diabetics over vials injected with syringes, due to its accuracy, ease of dosing, and reduced ...

Novo Nordisk’s insulin brand Mixtard will continue to be available in vials, the Danish healthcare company clarified, even as it phases out its penfill. The penfill is being phased out as part ...

Reaction to this move, however, has been relatively muted. “I don’t think [the new directive] will move the needle much,” Genevieve Kanter, an associate professor of public policy at the University of ...